STOCK TITAN

Jupiter Neurosciences (JUNS) director converts 82,875 RSUs into common stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

JUPITER NEUROSCIENCES, INC. director Julie B. Kampf reported the vesting and exercise of 82,875 restricted stock units on June 2, 2025. These RSUs converted into common stock on a one-for-one basis at $0.00 per unit upon expiration of the IPO lock-up period, leaving her with 82,875 common shares held directly.

Positive

  • None.

Negative

  • None.
Insider Kampf Julie B.
Role Director
Type Security Shares Price Value
Exercise Restricted Stock Units 82,875 $0.00 --
Exercise Common Stock 82,875 -- --
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct); Common Stock — 82,875 shares (Direct)
Footnotes (1)
  1. These restricted stock units convert into common stock on a one-for-one basis. Represents restricted stock units which vested on the expiration of the lock-up period for the Issuer's initial public offering.
RSUs Exercised 82,875 units Restricted stock units converted into common stock on June 2, 2025
Common Shares Received 82,875 shares Shares of common stock issued upon RSU conversion
Post-transaction Holdings 82,875 shares Total common stock held directly by Julie B. Kampf after transactions
RSU Conversion Price $0.00 per unit Price per restricted stock unit upon conversion to common stock
RSU Expiration Date December 17, 2033 Expiration date listed for the restricted stock unit award
Exercise Date June 2, 2025 Date RSUs vested and converted into common stock
Restricted Stock Units financial
"Represents restricted stock units which vested on the expiration"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
lock-up period financial
"vested on the expiration of the lock-up period for the Issuer's"
A lock-up period is a fixed time after a stock offering during which company insiders and early investors are legally barred from selling their shares. It matters because when that restriction expires a large block of previously locked-up shares can enter the market at once, potentially lowering the stock price or spiking trading volume—like opening a floodgate—so investors monitor these dates to anticipate price moves and manage risk.
initial public offering financial
"lock-up period for the Issuer's initial public offering"
An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did JUNS director Julie B. Kampf report on this Form 4?

Julie B. Kampf reported the exercise of 82,875 restricted stock units, converting them into an equal number of JUPITER NEUROSCIENCES, INC. common shares on June 2, 2025.

How many JUNS common shares does Julie B. Kampf hold after the reported transactions?

Following the reported transactions, Julie B. Kampf holds 82,875 shares of common stock of JUPITER NEUROSCIENCES, INC., all reported as direct ownership.

What was the price per share for the RSU conversion reported for JUNS?

The restricted stock units converted into JUPITER NEUROSCIENCES, INC. common stock at a price of $0.00 per unit, reflecting a standard compensation-related vesting rather than a market purchase.

What type of securities did the JUNS RSUs convert into for Julie B. Kampf?

The restricted stock units converted into common stock on a one-for-one basis, resulting in 82,875 JUNS common shares being issued upon vesting of the award.

Why did the JUNS restricted stock units vest on June 2, 2025?

The filing states that the restricted stock units vested on June 2, 2025 upon the expiration of the lock-up period related to JUPITER NEUROSCIENCES, INC.’s initial public offering.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kampf Julie B.

(Last)(First)(Middle)
C/O JUPITER NEUROSCIENCES, INC.
11621 KEW GARDENS AVE, SUITE 210

(Street)
PALM BEACH GARDENS FLORIDA 33410

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
JUPITER NEUROSCIENCES, INC. [ JUNS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/02/2025
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/02/2025M82,875A(1)82,875D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)06/02/2025M82,875 (2)12/17/2033Common Stock82,875$0.000D
Explanation of Responses:
1. These restricted stock units convert into common stock on a one-for-one basis.
2. Represents restricted stock units which vested on the expiration of the lock-up period for the Issuer's initial public offering.
/s/ Julie B. Kampf07/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)